Skip to content

TMO

Thermo Fisher Scientific Inc.

Free cash flow, 2025
$6.3B
YoY, 2025
−13.4%
5-year CAGR
−1.6%
10-year CAGR
+9.6%

Free cash flow

Free cash flow by fiscal year

PeriodFree cash flowYoY
2025$6.3B−13.4%
2024$7.3B+4.9%
2023$6.9B+0.2%
2022$6.9B+1.8%
2021$6.8B−0.4%
2020$6.8B+68.4%
2019$4.0B+6.9%
2018$3.8B+8.2%
2017$3.5B+24.3%
2016$2.8B+11.7%
2015$2.5B+14.9%
2014$2.2B+26.8%
2013$1.7B+0.2%
2012$1.7B+20.6%
2011$1.4B+14.2%
2010$1.3B−14.2%
2009$1.5B+26.3%
2008$1.2B−11.6%
2007$1.3B—